Substance / Medication

Metaproterenol

Overview

Active Ingredient
metaproterenol
RxNorm CUI
7688

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

369 trials linked to this intervention

369
Total Trials
42
Recruiting
119
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Deployment as a Risk Factor of Rhinologic Disease: Systematic Review and Meta-Analysis.
Briggs Erin E, Schlosser Nathaniel J, Nguyen Shaun A et al. · Mil Med · 2026
PMID: 40574701Meta-Analysis
The Impact of War on Asthma, a Systematic Review and Meta-Analysis: An EAACI Task Force Report.
Cavaleiro Rufo João, Paciência Inês, Jutel Marek et al. · Allergy · 2026
PMID: 40906435Meta-AnalysisFull text (PMC)
Predictors of Response to Biologics for Severe Asthma: A Systematic Review and Meta-Analysis.
Rattu Anna, Dixey Piers, Charles David et al. · Allergy · 2026
PMID: 40956008Meta-AnalysisFull text (PMC)
Impact of adenotonsillectomy on asthma control in children: a systematic review and meta-analysis of clinical outcomes.
Alenezi Mohamad Ahmad M, Alaradi Tariq Salem E, Alruwaili Ziyad Mutarid M et al. · J Asthma · 2026
PMID: 41111458Meta-Analysis
Metabolic effects of metaproterenol overdose: hypokalemia, hyperglycemia and hyperlactatemia.
Barnewolt B A, Walter F G, Bey T A · Vet Hum Toxicol · 2001
PMID: 11383657Case Report
The role of alcohol extract of cranberry in improving serum indices of experimental metaproterenol-induced heart damage in rats.
Salmasi Kimia, Hassanpour Ali, Amouoghli Tabrizi Bahram et al. · Food Sci Nutr · 2023
PMID: 37823158OtherFull text (PMC)
Metaproterenol, isoproterenol, and their bisdimethylcarbamate derivatives as human cholinesterase inhibitors.
Bosak Anita, Gazić Smilović Ivana, Sinko Goran et al. · J Med Chem · 2012
PMID: 22817559Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Orciprenaline (substance)
SNOMED CT
372797004
UMLS CUI
C0029193
RxNorm CUI
7688

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

3
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
369
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.